Breaking News

Piramal Pharma Achieves Improved Score on Global Corporate Sustainability Assessment

The S&P Global CSA analyzes companies on environmental, social, and governance performance, governance maturity, and long-term value creation.

Author Image

By: Charlie Sternberg

Associate Editor

Piramal Pharma Limited (PPL) has achieved a score of 63 on the 2025 S&P Global Corporate Sustainability Assessment (CSA). This marks a substantial 15% improvement over last year’s score of 55, reflecting the company’s ongoing commitment to sustainability and responsible operations. The S&P Global CSA assesses the sustainability performance of thousands of companies across various industries, analyzing them on criteria like environmental, social, and governance (ESG) performance,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters